https://www.business-standard.com/article/companies/alembic-s-affiliate-rhizen-bags-us-fda-nod-for-oral-lymphoma-drug-121020900720_1.html
Company says a critical cancer inhibiting component in the formulation is the first new chemical entity discovered by Indian scientists to secure US FDA nod
Alembic’s affiliate Rhizen bags US FDA nod for oral lymphoma drug
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- Eli Lilly promises to make new weight loss pill in the U.S.
More from UncategorizedMore posts in Uncategorized »
- Gold ends week higher despite Powell’s pushback, trade uncertainty lingers
- EUR/USD climbs as US Dollar weakens on trade tensions
- Forex Today: Markets stabilize as trading volume thins out on Easter Friday
- US Dollar Index hovers near 99.50 as trading activity remains muted due to Good Friday
- Follow the leaders
- Starbucks gets a new dress code, Tesla falls behind, and Trump wants Powell out: Business news roundup
- Tumbling stocks, recession fears, and a retail sales surge: Markets news roundup
- Meta’s antitrust trial, Nvidia’s stateside manufacturing, and 7 AI breakthroughs: Tech news roundup
- Meta’s antitrust trial heats up: Here’s what we’ve learned so far
- Eli Lilly promises to make new weight loss pill in the U.S.